Modulatory neurotransmitter systems and behavior: Towards zebrafish models of neurodegenerative diseases

Zebrafish

Volumn 3, Issue 2, 2006, Pages 235-247

  Panula, Pertti ^a   Sallinen, Ville ^a   Sundvik, Maria ^a   Kolehmainen, Juha ^a   Torkko, Veera ^a   Tiittula, Anu ^a   Moshnyakov, Maxim ^a   Podlasz, Piotr ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745540146     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2006.3.235     Document Type: Review

References (120)

1. Mullins MC, Hammerschmidt M, Haffter P, Nusslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 1994;4:189-202.
2. Golling G, Amsterdam A, Sun Z, Antonelli M, Maldonado E, Chen W, et al. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 2002;31:135-140.
3. Driever W, Solnica-Krezel L, Schier AF, Neuhauss SC, Malicki J, Stemple DL, et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996;123:37-46.
4. Schier AF, Neuhauss SC, Harvey M, Malicki J, Solnica-Krezel L, Stainier DY, et al. Mutations affecting the development of the embryonic zebrafish brain. Development 1996;123:165-178.
5. Brand M, Heisenberg CP, Jiang YJ, Beuchle D, Lun K, Furutani-Seiki M, et al. Mutations in zebrafish genes affecting the formation of the boundary between midbrain and hindbrain. Development 1996;123:179-190.
6. Abdelilah S, Mountcastle-Shah E, Harvey M, Solnica-Krezel L, Schier AF, Stemple DL, et al. Mutations affecting neural survival in the zebrafish Danio rerio, Development 1996;123:217-227.
7. Furutani-Seiki M, Jiang YJ, Brand M, Heisenberg CP, Houart C, Beuchle D, et al. Neural degeneration mutants in the zebrafish, Danio rerio. Development 1996;123:229-239.
8. Ninkovic J, Tallafuss A, Leucht C, Topczewski J, Tannhauser B, Solnica-Krezel L, et al. Inhibition of neurogenesis at the zebrafish midbrain-hindbrain boundary by the combined and dose-dependent activity of a new hairy/E(spl) gene pair. Development 2005;132:75-88.
9. Rhinn M, Lun K, Luz M, Werner M, Brand M. Positioning of the midbrain-hindbrain boundary organizer through global posteriorization of the neuroectoderm mediated by Wnt8 signaling. Development 2005;132:1261-1272.
10. Peichel CL. Social behavior: how do fish find their shoal mate? Curr Biol 2004;14:R503-504.
11. Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav 2004;3:63-74.
12. Kuo PD, Eliasmith C. Integrating behavioral and neural data in a model of zebrafish network interaction. Biol Cybern 2005;93:178-187.
13. Hokfelt T, Ljungdahl A, Fuxe K, Johansson O. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science 1974;184:177-179.
14. Mudd SH, Freeman JM. N-5,10-methylenetetrahydrofolate reductase deficiency and schizophrenia: a working hypothesis. J Psychiatr Res 1974;11:259-262.
15. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217-1219.
16. Akhondzadeh S. The 5-HT hypothesis of schizophrenia. IDrugs 2001;4:295-300.
17. Hirvonen J, van Erp TG, Huttunen J, Nagren K, Huttunen M, Aalto S, et al. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia. Psychiatry Res 2006:146:13-20.
18. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005;10:434-449.
19. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997;28:1-38.
20. Singh SM, Murphy B, O'Reilly RL. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin Genet 2003;64:451-460.
21. Rosegay H. An experimental investigation of the connections between the corpus striatum and substantia nigra in the cat. J Comp Neurol 1944;80:293-321.
22. Anden NE, Carlsson A, Dahlstr̂m A, Fuxe K, Hillarp NA, Larsson K. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci 1964;15:523-530.
23. McNeill TH, Brown SA, Rafols JA, Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988;455: 148-152.
24. Anichtchik OV, Huotari M, Peitsaro N, Haycock JW, Mannisto PT, Panula P. Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 2000;12:1-12.
25. Anichtchik OV, Rinne JO, Kalimo H, Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 2000b;163:20-30.
26. Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 2002;81:954-960.
27. Parvathy S, Buxbaum JD. Molecular genetics of Alzheimer disease. In: Neuropsychopharmacology: The Fifth Generation of Progress. KL Dennis, D Charnay, JT Coyle, C Nemeroff (eds.). Lippincott, Philadelphia. 2002:1999-2013.
28. Kamboh MI. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 2004;68:381-404.
29. Rademakers R, Cruts M, Van Broeckhoven C. Genetics of early-onset Alzheimer dementia. TheScientificWorld 2003;3:497-519.
30. Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Rev 2005;49:618-632.
31. Smith CM, Swash M. Possible biochemical basis of memory disorder in Alzheimer disease. Ann Neurol 1978;3:471-473.
32. Nixon RA. Cell and molecular neuropathology of Alzheimer disease. In: Neuropsychopharmacology: The Fifth Generation of Progress. KL Dennis, D Charnay, JT Coyle, C Nemeroff (eds.). Lippincott, Philadelphia. 2002:1221-1229.
33. Airaksinen MS, Paetau A, Paljärvi L, Reinikainen K, Riekkinen P, Suomalainen R, et al. Histamine neurons in human hypothalamus: Anatomy in normal and Alzheimer diseased brains. Neuroscience 1991;44:465-481.
34. Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sailmen T, Kalimo H, et al. Neuronal histamine deficit in Alzheimer's disease. Neuroscience 1998;82:993-997.
35. Haas HL, Panula P. The role of histamine and the tuberomamillary nucleus in the brain. Nat Rev Neurosci 2003;4:121-130.
36. Eriksson KS, Peitsaro N, Karlstedt K, Kaslin J, Panula P. Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neurosci 1998;10:3799-3812.
37. Guo S, Wilson SW, Cooke S, Chitnis AB, Driever W, Rosenthal A. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol 1999a;208:473-487.
38. Guo S, Brush J, Teraoka H, Goddard A, Wilson SW, Mullins MC, et al. Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/ Phox2a. Neuron 1999b;24:555-566.
39. Guo S, Yamaguchi Y, Schilbach S, Wada T, Lee J, Goddard A, et al. A regulator of transcriptional elongation controls vertebrate neuronal development. Nature 2000;408:366-369.
40. Holzschuh J, Ryu S, Aberger F, Driever W. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 2001;101:237-243.
41. McLean DL, Fetcho JR. Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish. J Comp Neurol 2004;480:38-56.
42. Ma PM. Catecholaminergic systems in the zebrafish. II. Projection pathways and pattern of termination of the locus coeruleus. J Comp Neurol 1994;344:256-269.
43. Ma PM. Catecholaminergic systems in the zebrafish. III. Organization and projection pattern of medullary dopaminergic and noradrenergic neurons. J Comp Neurol 1997;381:411-427.
44. Kaslin J, Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 2001;440:342-377.
45. Ekström P, Van Veen T. Distribution of 5-hydroxytryptamine (serotonin) in the brain of the teleost Gasterosteus aculeatus L. J Comp Neurol 1984;226:307-320.
46. Hornby PJ, Piekut DT, Demski LS. Localization of immunoreactive tyrosine hydroxylase in the goldfish brain. J Comp Neurol 1987;261:1-14.
47. Kaslin J, Nystedt JM, Östergård M, Peitsaro N, Panula P. The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neuroscience 2004;24:2678-2689.
48. Peitsaro N, Kaslin J, Anichtchik O, Panula P. Modulation of the histaminergic system and behavior by alpha-fluoromethylhistidine in zebrafish. J Neurochem 2003;86:432-441.
49. Anichtchik OV, Kaslin J, Peitsaro N, Scheinin M, Panula P. Neurochemical and behavioral changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 2004;88:443-453.
50. Panula P, Yang HY, Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 1984;81:2572-2576.
51. Ruuskanen JO, Peitsaro N, Kaslin JV, Panula P, Scheinin M. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. J Neurochem 2005;94:1559-1569.
52. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005;28:57-87.
53. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-980.
54. Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309-310.
55. Przedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disord 1998;13:35-38.
56. Tipton KF, Singer TP. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 1993;61:1191-1206.
57. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 1983;80:4546-4550.
58. Heikkila RE, Sonsalla PK. The use of the MPTP-treated mouse as an animal model of parkinsonism. Can J Neurol Sci 1987;14:436-440.
59. Mori S, Fujitake J, Kuno S, Sano Y. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci Lett 1988;90:57-62.
60. Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 1989;494:285-293.
61. Beal MF. Experimental models of Parkinson's disease. Nat Rev Neurosci 2001;2:325-334.
62. Pollard HB, Dhariwal K, Adeyemo OM, Markey CJ, Caohuy H, Levine M, et al. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. FASEB J 1992;6:3108-3116.
63. Pollard HB, Kuijpers GA, Adeyemo OM, Youdim MB, Coping G. The MPTP-induced parkinsonian syndrome in the goldfish is associated with major cell destruction in the forebrain and subtle changes in the optic tectum. Exp Neurol 1996;142:170-178.
64. Adeyemo OM, Youdim MB, Markey SP, Markey CJ, Pollard HB. L-Deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. Eur J Pharmacol 1993;240:185-193.
65. Chen K, Wu HF, Grimsby J, Shih JC. Cloning of a novel monoamine oxidase cDNA from trout liver. Mol Pharmacol 1994;46:1226-1233.
66. Kumazawa T, Seno H, Ishii A, Suzuki O, Sato K. Monoamine oxidase activities in catfish (Parasilurus asotus) tissues. J Enzyme Inhib 1998;13:377-384.
67. Nicotra A, Senatori O. Some characteristics of mitochondrial monoamine oxidase activity in eggs of carp (Cyprinus carpio) and rainbow trout (Salmo gairdneri). Comp Biochem Physiol C 1989;92:401-404.
68. Obata T, Yamanaka Y, Sho S, Kinemuchi H. Isoelectric analysis of 3H-pargyline-labelled monoamine oxidase in rat and carp. Comp Biochem Physiol C 1990;96:91-98.
69. Anichtchik O, Sallinen V, Peitsaro N, Panula P. Identification and distribution of monoamine oxidase in the brain of zebrafish Danio rerio. Program No. 164.18. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004b.
70. Setini A, Pierucci F, Senatori O, Nicotra A Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp Biochem Physiol B Biochem Mol Biol 2005;140:153-161.
71. Noldus LP, Spink AJ, Tegelenbosch RA. EthoVision: a versatile video tracking system for automation of behavioral experiments. Behav Res Methods Instrum Comput 2001;33:398-414.
72. Nilsson GE, Rosén P, Johansson D. Anoxic depression of spontaneous locomotor activity in crucian carp quantified by a computerized imaging technique. J Exp Biol 1993;180:153-162.
73. Kato S, Tamada K, Shimada Y, Chujo T. A quantification of goldfish behavior by an image processing system. Behav Brain Res 1996;80:51-55.
74. Brewer SK, Little EE, DeLonay AJ, Beauvais SL, Jones SB, Ellersieck MR. Behavioral dysfunctions correlate to altered physiology in rainbow trout (Oncorynchus mykiss) exposed to cholinesterase-inhibiting chemicals. Arch Environ Contam Toxicol 2001;40:70-76.
75. Beauvais SL, Jones SB, Parris JT, Brewer SK, Little EE. Cholinergic and behavioral neurotoxicity of carbaryl and cadmium to larval rainbow trout (Oncorhynchus mykiss). Ecotoxicol Environ Safety 2001;49:84-90.
76. Petzinger GM, Jakowec MM. Animal models of basal ganglia injury and degeneration and their application to Parkinson's disease research. In: Parkinson's disease. M Ebadi, F Pfeiffer F (eds.). CRC Press, Boca Raton. 2005:367-399.
77. Contestabile A, Friz T, Caravaggio MV. Disappearance and recovery of catecholamine innervation in brain regions of adult goldfish following 6-hydroxydopamine treatment. Neurosci Lett 1979;14:333-337.
78. Clements S, Schreck CB, Larsen DA, Dickhoff WW. Central administration of corticotropin-releasing hormone stimulates locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha). Gen Comp Endocrinol 2002;125:319-327.
79. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 2005;141:128-137.
80. Lam CK, Korzh V, Strähle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 2005;21:1758-1762.
81. Bretaud S, Lee S, Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 2004;26:857-864.
82. Poli A, Guarnieri T, Facchinetti F, Villani L. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in goldfish brain. Brain Res 1990a;534:45-50.
83. Goping G, Pollard HB, Adeyemo OM, Kuijpers GA Effect of MPTP on dopaminergic neurons in the goldfish brain: a light and electron microscope study. Brain Res 1995;687:35-52.
84. Rink E, Wullimann MF. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 2001;889:316-330.
85. Easter SS Jr, Nicola GN. The development of vision in the zebrafish (Danio rerio). Dev Biol 1996;180:646-663.
86. Brockerhoff SE, Hurley JB, Janssen-Bienhold U, Neuhauss SC, Driever W, Dowling JE. A behavioral screen for isolating zebrafish mutants with visual system defects. Proc Natl Acad Sci USA 1995;92:10545-10549.
87. Li L, Dowling JE. Effects of dopamine depletion on visual sensitivity of zebrafish. J Neurosci 2000;20:1893-1903.
88. Gerlai R, Lahav M, Guo S, Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000;67:773-782.
89. Darland T, Dowling JE. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci USA 2001;98:11691-11696.
90. Coelho JL, Medalha CC, Mattioli R. Analysis of the effects of CPA and L-histidine on goldfish tested on a conditioned place preference model. Behav Brain Res 2001;124:161-165.
91. Sundvik M. The zebrafish, Danio rerio, as a model organism in behavioral studies: conditioned fear and evaluation of Fos as a marker for neuronal activity. MSc thesis, Abo Akademi University, Turku. 2004:53 pp.
92. Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 2000;26:129-130.
93. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RHA, Cuppen E. Efficient target-selected mutagenesis in zebrafish. Genome Res 2003;X:2700-2707.
94. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Deheija A, Dutra A, et al. Mutation in the alfa-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
95. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. Alfa-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
96. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recesssive juvenile parkinsonism. Nature 1998;392:605-608.
97. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in parkinson's disease. Nature 1998;395:451-452.
98. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-1160.
99. Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, et al. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003;24:159-160.
100. Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005;57:918-921.
101. Gandhi S, Wood NW. Molecular pathogenesis of Parkinson's disease. Hum Mol Genet 2005;14:2749-2755.
102. Golbe LI. Alpha-synuclein and Parkinson's disease. In: Parkinson's disease. M Ebadi, F Pfeiffer F (eds.). CRC Press, Boca Raton. 2005:117-127.
103. Gasser T. Parkin and its role in Parkinson's disease. In: Parkinson's disease. M Ebadi, F Pfeiffer F (eds.). CRC Press, Boca Raton. 2005:129-137.
104. Pankratz N, Faroud T. Other mutations: their role in Parkinson's disease. In: Parkinson's disease. M Ebadi, F Pfeiffer (eds.). CRC Press, Boca Raton. 2005; 159-167.
105. Son OL, Kim HT, Ji MH, Yoo KW, Rhee M, Kim CH. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Biochem Biophys Res Comm 2003;312:601-607.
106. Kamboh, MI. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet. 2004;68:381-404.
107. Tsuang MT, Owen MJ. Molecular and population genetics of schizophrenia. In: Neuropsychopharmacology: The fifth generation of progress. KL Davis, D Charney, JT Coyle, C Nemeroff (eds). Lippincott, Philadelphia. 2002;671-687.
108. Moens CB, Prince VE. Constructing the hindbrain: insights from the zebrafish. Dev Dyn 2002;224:1-17.
109. Fetcho JR, O'Malley DM. Visualization of active neural circuitry in the spinal cord of intact zebrafish. J Neurophysiol 1995;73:399-406.
110. O'Malley DM Zhou Q, Gahtan E. Probing neural circuits in the zebrafish: a suite of optical techniques. Methods 2003;30:49-63.
111. Brustein E, Chong M, Holmqvist B, Drapeau P. Serotonin patterns locomotor network activity in the developing zebrafish by modulating quiescent periods. J Neurobiol 2003;57:303-332.
112. Friedrich RW, Laurent G. Dynamic optimization of odor representations in the olfactory bulb by slow temporal patterning of mitral cell activity. Science 2001;291:889-894.
113. Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, et al. Fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 1992;8:13-23.
114. Baraban SC, Taylor MR, Castro PA, Baier H. Pentylenetetrazole induced chagnes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005;131:759-768.
115. Larson ET, O'Malley DM, McCann TE, Melloni RH. Differential neuronal activation patterns are associated with dominant-subordinate relationships in zebrafish. Behav Brain Res 2006 ;167:94-102.
116. Liu KS, Fetcho JR. Laser ablations reveal functional relationships of segmental hindbrain neurons in zebrafish. Neuron 1999;23:325-335.
117. Roeser T, Baier H. Visuomotor behaviors in larval zebrafish aftger GFP-guided laser ablation of the optic tectum. J Neurosci 2003;23:3726-3734.
118. Gahtan E, O'Malley DM. Rapid lesioning of large numbers of identified vertebrate neurons: applications in zebrafish. J Neurosci Methods 2001;108:97-110.
119. Neuhauss SC, Biehlmaier O, Seeliger MW, Das T, Kohler K, Harris WA, et al. Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J Neurosci 1999;19:8603-8615.
120. Muto A, Orger MB, Wehman AM, Smear MC, Kay JN, Page-McCaw PS, et al. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet 2005;1:e66.